Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|July 13, 2011
Light-directed delivery of nucleic acidsSigurd Bøe, Lina Prasmickaite, Birgit Engesæter, et al.
Plos One|April 23, 2025
Cervical intraepithelial neoplasia grade 1 and long-term risk of progression and treatmentIngrid Baasland, Tone Bjørge, Birgit Engesæter, et al.
Plos One|October 3, 2012
Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanomaBirgit Engesæter, Olav Engebraaten, Vivi Ann Flørenes, et al.
European Journal of Public Health|September 29, 2018
The legal framework for European cervical cancer screening programmesOndřej Májek, Ahti Anttila, Marc Arbyn, et al.
International Journal of Cancer|February 8, 2025
Risk of high-grade cervical lesions in the second round of primary human papillomavirus testing in CervicalScreen Norway: A population-based cohort studyTone Bjørge, Nathalie C Støer, Sara K Hverven, et al.
British Journal of Cancer|April 4, 2020
Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screeningDana Hashim, Birgit Engesæter, Gry Baadstrand Skare, et al.
Cell Death Discovery|December 29, 2016
hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanomaKarianne G Fleten, Vivi Ann Flørenes, Lina Prasmickaite, et al.
Biochemical and Biophysical Research Communications|March 27, 2012
Synthetic retinoid CD437 induces apoptosis and acts synergistically with TRAIL receptor-2 agonist in malignant melanomaGry Irene Magnussen, Anne Katrine Ree Rosnes, Susan Shahzidi, et al.
BMJ Open|February 11, 2017
Impact of scheduled appointments on cervical screening participation in Norway: a randomised interventionStefan Lönnberg, Trude Andreassen, Birgit Engesæter, et al.
BMC Cancer|June 10, 2015
Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanomaGry Irene Magnussen, Elisabeth Emilsen, Karianne Giller Fleten, et al.
Pageof 2